Activity and biotransformation of three synthetic "legal highs": Mephedrone, methylone and 3,4-methylenodioxypyrovalerone

Problems of Forensic Sciences

Volumn 89, Issue , 2012, Pages 71-85

  Ciechomska, Monika ^a   Woźniakiewicz, Michał ^a   Wietecha Posłuszny, Renata ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

"Legal highs"; Biotransformation; MDPV; Mephedrone; Methylone

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 3,4 METHYLENODIOXYPYROVALERONE; 4' METHYLMETHCATHINONE; ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; COCAINE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; DOPAMINE; EPHEDRINE; METHYLONE; NORADRENALIN; PERMANGANATE POTASSIUM; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; SEROTONIN; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER;

ABDOMINAL PAIN; ANHEDONIA; ANXIETY; ATTENTION DEFICIT DISORDER; BIOTRANSFORMATION; BLURRED VISION; BODY FLUID; BRUXISM; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CONFUSION; DEACETYLATION; DECREASED APPETITE; DEHYDROGENATION; DELUSION; DEMETHYLATION; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG DEPENDENCE; DRUG EFFECT; DRUG EXCRETION; DRUG METABOLISM; DYSPNEA; EPISTAXIS; EPOXIDATION; EUPHORIA; FATIGUE; HALLUCINATION; HEADACHE; HEART PALPITATION; HEMOLYTIC ANEMIA; HUMAN; HYDROXYLATION; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INGESTION; INSOMNIA; IRRITABILITY; LD 50; MEMORY DISORDER; METHEMOGLOBINEMIA; MYDRIASIS; NAUSEA; NEUROTOXICITY; OXIDATION; PANIC; PARANOIA; PARESTHESIA; PARKINSONISM; REVIEW; SEXUAL AROUSAL; SKIN BRUISING; SUICIDAL IDEATION; SWEATING; TACHYCARDIA; TRISMUS; VASOCONSTRICTION; VOMITING; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 84862151728     PISSN: 12307483     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Adamowicz P., Tokarczyk B., Stanaszek R. [i in.], Śmiertelne zatrucie mefedronem, XXVIII Konferencja Toksykologów Sa̧dowych, Szklarska Porȩba, 18-20.05.2011.
2. Bossong M. G., van Dijk J. P., Niesink R. J. M., Methylone and mCPP, two new drugs of abuse?, Addiction Biology 2005, 10, 321-323. (Pubitemid 41759265)
3. Dargan P. I., Albert S., Wood D. M., Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change, Quarterly Journal of Medicine 2010, 103, 875-879.
4. Deluca P., Schifano F., Davey Z., MDPV Report: Psychnaut Web Mapping Research Project, Institute of Psychiatry, London 2009.
5. Europol-EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone), European Monitoring Centre for Drugs and Drug Addiction, 27.05.2010 [www.emcdda.europa.eu (02.05.2011)].
6. Europol-EMCDDA on-line sales of new psychoactive substances/"legal highs": summary of results from the 2011 multilingual snapshots, European Monitoring Centre for Drugs and Drug Addiction, 27.05.2010 [www.emcdda.europa.eu (23.01.2012)].
7. Gibbons S., Zloh M., An analysis of the "legal high"mephedrone, Bioorganic & Medicinal Chemistry Letters 2010, 20, 4135-4139.
8. Kamata H. T., Shima N., Zaiksu K. [et al.], Simultaneous analysis of new designer drug, methylone, and its metabolites in urine by gas chromatography mass spectrometry and liquid chromatography - electrospray ionization mass spectrometry, Japanese Journal of Forensic Science and Technology 2007, 12, 97-106.
9. Kamata H. T., Shima N., Zaiksu K. [et al.], Metabolism of the recently encountered designer drug, methylone, in humans and rats, Xenobiotica 2006, 36, 709-723. (Pubitemid 44195985)
10. McElrath K., O'Neill C., Experiences with mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply, International Journal of Drug Policy 2011, 22, 120-127.
11. Meyer M. R., Du P., Schuster F. [et al.], Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS, Journal of Mass Spectrometry 2010, 45, 1426-1442.
12. Meyer M. R., Wilhelm J., Peters F. T. [et al.], Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry, Analytical and Bioanalytical Chemistry 2010, 397, 1225-1233.
13. Nagai F., Nonaka R., Kamimura K. S. H., The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain, European Journal of Pharmacology 2006, 559, 132-137.
14. Namieśnik J., Jaśkowski J., Zarys ekotoksykologii, EKOPharma, Gdańsk 1995.
15. Ojanperä I. A., Heikman P. K., Rasanen I. J., Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry, Therapeutic Drug Monitoring 2011, 33, 257-263.
16. Piotrowski J. K., Podstawy toksykologii, Wydawnictwa Naukowo-Techniczne, Warszawa 2008.
17. Shimizu E., Watanabe H., Kojima T. [et al.], Combined intoxication with methylone and 5-MeO-MIPT, Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31, 288-291.
18. Stepens A., Logina I., Liguts V. [et al.], A Parkinsonian Syndrome in methcathinone users and the role of manganese, The New England Journal of Medicine 2008, 358, 1009-1017. (Pubitemid 351347100)
19. Strano-Rossi S., Cadwallader A. B., de la Torre X. [et al.], Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MPDV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry, Rapid Communications in Mass Spectrometry 2010, 24, 2706-2714.
20. Torrance H., Cooper G., The detection of mephedrone (4- methylmethcathinone) in 4 fatalities in Scotland, Forensic Science International 2010, 202, e62-e63.
21. Ustawa z dnia 8 października 2010 r. o zmianie Ustawy o przeciwdziałaniu narkomanii oraz ustawy o Pañstwowej Inspekcji Sanitarnej, Dziennik Ustaw 2010, 213, poz. 1396.
22. Ustawa z dnia 10 czerwca 2010 r. o zmianie Ustawy o przeciwdział aniu narkomanii, Dziennik Ustaw 2010 r., 143, poz. 962.
23. Ustawa z dnia 20 marca 2009 r. o zmianie Ustawy o przeciwdziałaniu narkomanii, Dziennik Ustaw 2009, 63, poz. 520.
24. Westphal F., Junge T., Rösner P. [et al.], Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: A designer drug with á-pyrrolidinophenone structure, Forensic Science International 2009, 190, 1-8.
25. Winstock A. R., Mitcheson L. R., Deluca P. [et al.], Mephedrone, new kid for the chop?, Addiction 2010, 106, 154-161.
26. Wood D. M., Greene S. L., Dargan P. I., Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone, Emergency Medicine Journal 2011, 28, 280-282.